跳至主要内容
临床试验/NCT05996796
NCT05996796已完成不适用

Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: Dry Run of the ScreenUrSelf Trial

Universiteit Antwerpen2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2023年4月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
2
主要终点
HPV DNA using the Riatol qPCR HPV genotyping assay

研究概览

简要总结

The proposed study is the Dry Run preceding the ScreenUrSelf trial.

详细描述

The ScreenUrSelf trial will be embedded in the Flemish organized cervical cancer screening program. The goal of ScreenUrSelf is to reach women who are eligible but do not participate in cervical cancer screening, by offering two self-sampling methods (first-void urine and vaginal) in an opt-in and -out strategy (total of four interventions) to collect samples for primary high-risk (hr) Human Papillomavirus (HPV) testing, and if positive, reflex 1) cytology on a Pap smear (standard of care) and 2) methylation marker triage (index test). The two control arms include 1) no intervention; and 2) sending (recall) invitation letters to women, inviting them to make an appointment for a Pap smear (i.e., current practice within the organized cervical cancer screening program in Flanders).

The Dry Run which is the subject of this clinical trial will test the study materials and data flows developed for the interventional study arms (C, D, E and F) of the ScreenUrSelf trial. The primary outcome of the Dry Run is to check if the flow for data- and sample collection is ready for start of the ScreenUrSelf trial, and if optimizations are deemed necessary before start of the trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
30 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Eligible for cervical cancer screening within the organized Population-based Screening Program in Flanders:
  • Residing in Flanders, Belgium
  • No history of total hysterectomy
  • No (former) diagnosis of cervical or uterine cancer
  • 30 - 64 years old (birth year 1959 - 1992)

排除标准

  • Being pregnant or 6 weeks postpartum (self-reported after receiving the study letter/package)
  • Participation during menstruation or within the 3 following days is a contraindication
  • Not able to understand the study materials and participation form (informed consent form)

结局指标

主要结局

HPV DNA using the Riatol qPCR HPV genotyping assay

时间窗: Through study completion, an average of 1 year

HPV DNA concentration \[copies/µl DNA\] in self-samples from all study participants.

次要结局

  • Human DNA (Beta-globin) using the Riatol qPCR HPV genotyping assay(Through study completion, an average of 1 year)
  • Preferences(Through study completion, an average of 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pierre Van Damme

Principal Investigator

Universiteit Antwerpen

研究点 (2)

Loading locations...

相似试验